Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 9, 2023

Primary Completion Date

January 3, 2026

Study Completion Date

December 9, 2026

Conditions
Female Infertility
Interventions
BIOLOGICAL

Intrauterine administration of autologous peripheral blood mononuclear cells (PBMC)

Approximately 9 ml blood from each patient will be collected on the day of the LH peak by peripheral venipuncture using a 21G butterfly catheter affixed via vacutainer to negative pressure receiving tubes (BD vacutainer acid-citrate-dextrose (ACD-A), REF:366645). PBMC will be isolated by density gradient centrifugation in room-temperature centrifuge set to 400 g for 25 min. PBMCs (1x106cells/ml) suspended in RPMI 1640 supplemented with 10% HSA will be incubated in the presence of 10 IU/ml hHCG for 48 h. On day 2 after LH peak, fresh PBMCs (1x107 cells) will be also obtained from the same patients, these fresh PBMCs will be immediately combined with the 2-day cultured PBMC and suspended in PBS (2x107 cells/200µl). This cell suspension will be carefully introduced in the uterine cavity by catheter on day 2 after LH peak.

Trial Locations (2)

1373

RECRUITING

Nadezhda Women's Health Hospital, Sofia

RECRUITING

Medical diagnostic laboratory Imunovita, Sofia

All Listed Sponsors
collaborator

Medical diagnostic laboratory ImunoVita

UNKNOWN

lead

Nadezhda Women's Health Hospital

OTHER